Catalyst
Slingshot members are tracking this event:
Cara Therapeutics (CARA) Initiates Enrollment of Phase 2b Trial Evaluating Oral CR845 in Chronic Pain Patients
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| CARA |
|
|
||||
Slingshot Insights Explained
Catalyst Date
Occurred on:
Sep 15, 2016
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Phase 2b Enrollment Initiation, Peripherally Acting Kappa Opioid Agonist, Oral Cr845
